Be Aware of the Signs of Depression

 

Everyone has their ups and downs -- a period of several days or a week when they out of sorts and a little "blue." This usually passes, and you're able to resume your regular activities. However, this isn't the same as having clinical depression. Clinical depression is a medical illness.  It can come on suddenly, or it can creep up on you over a period of weeks and months. It can affect more than your mood. It can disrupt your eating, sleeping, or thinking patterns, and it can cause physical symptoms and changes. The good news is that depression is highly treatable. 

If you or a loved one has some, most or all of these warning signs of depression, don't ignore them. Share your feelings, and seek guidance and support from your health care provider.

  • Persistent sad, anxious, or empty mood
  • Loss of interest in activities once previously enjoyed
  • Excessive crying
  • Increased restlessness and irritability
  • Decreased ability to concentrate and make decisions
  • Decreased energy
  • Increased alcohol or drug use
  • Thoughts of death or suicide, or suicide attempts
  • Increased feelings of guilt, helplessness, and/or hopelessness
  • Weight and/or appetite changes due to over- or under-eating
  • Changes in sleep patterns
  • Social withdrawal
  • Physical symptoms such as fatigue, headaches, pain and insomnia

 For more information and resources, contact:

National Mental Health Association

800-969-6642

www.nmha.org

 

 

 

This content was last reviewed August 15, 2010 by Dr. Reshma L. Mahtani.
Latest Cancer News
REFILE: Komen charity under microscope for funding, science

February 8, 2012 — NEW YORK (Reuters) - The Susan G. Komen for the Cure charity defines its mission as finding a cure for breast cancer. In recent years, however, it has cut by nearly half the proportion of fund-raising dollars it spends on grants to scientists working to understand the causes and develop effective new treatments for the disease.

US FDA panel votes against wider use of Amgen drug

February 8, 2012 — WASHINGTON (Reuters) - An advisory panel on Wednesday recommended that U.S. health regulators reject the use of Amgen Inc's drug Xgeva to delay the spread of prostate cancer to the bone, dimming the chance of a wider use for one of the company's key growth drivers.

US consumers want tougher probe of engineered salmon

February 8, 2012 — WASHINGTON (Reuters) - Three U.S. consumer groups petitioned the Food and Drug Administration on Tuesday to subject a new genetically engineered salmon to a more rigorous review process than is now in place before the fish can be approved as safe to eat.

Select news items provided by Reuters Health